Of the four spontaneous mouse mutations resulting in impaired growth, the pygmy mouse is extraordinary because it has no aberrations in pathways involving growth hormone or insulin-like growth factors. The pygmy phenotype is caused by a defect in the HMGI-C gene, which is a member of the HMGI family of proteins (1, 2) .
HMGI proteins belong to a general class of high mobility group (HMG) DNA binding proteins (reviewed in (3)). These are ubiquitous and abundant non-histone nuclear proteins and are divided into three subfamilies. The HMG-1/-2 subfamily has the HMG-1 box as its major functional motif, which consists of approximately 80 amino acids. The box binds DNA to the minor groove and induces speci®c DNA deformations. A nucleosomal binding domain is the functional motif in the HMG-14/ -17 subfamily. Two molecules of HMG-14 or HMG-17 bind to the nucleosome core, which is the building block of the chromatin ®bre, and change the chromatin structure. The HMGI group is the third subfamily and consists of HMG-I and HMG-Y, which are encoded by the same gene and made by alternative splicing, and HMGI-C. The functional domain of these proteins is the AT hook, which is made of nine positively charged amino acids. They bind to the minor groove of DNA with relatively low speci®city with regard to the DNA sequence, and preferentially to the sequence AA(T/A)T. The proteins are a part of the structural elements of metaphase chromosomes. HMGI proteins may attenuate the inhibitory effect of the nuclear protein histone H1 on transcription by displacing H1 from DNA. They can also affect embryonic development by interfering with homeodomain binding proteins. In addition, the HMGI proteins can modulate the transcription of several genes. They may enhance or repress transcription by direct DNA interactions or by binding to speci®c transcription factors. Stimulatory effects of HMG-I/Y on transcription have been studied in detail on the virus-inducible enhancer of the interferon-b gene. Binding of HMG proteins stabilises DNA and speci®c transcription factors in a higher order nucleoprotein complex called an enhanceosome (reviewed in (4)).
The expression of HMGI-C has been studied in detail in mouse embryos (5) . At an early embryonic stage HMGI-C mRNA is found in all tissues, whereas the pattern of expression is restricted particularly to mesenchymal derivatives, some epithelial cell layers, and parts of the central nervous system in the second half of embryonic development.
HMGI-C expression is normally not detected in adult tissues from humans or mice (5, 6) . However, HMGI-C mRNA is frequently found in solid tumours in humans such as lipomas, pleomorphic adenomas of the salivary gland, uterine leiomyomas, and lung hamartomas. It has been shown that these tumours often have chromosome 12 rearrangements, which directly affect the HMGI-C gene on this chromosome (7) . Expression of HMGI-C seems to be linked to proliferation both in normal embryos and in tumour cells.
In a recent paper, Anand & Chada (8) showed that the expression of HMGI-C in fat depots from normal mice was detectable after 1 week of a high-fat diet. Expression of the gene was also observed in fat from the genetically obese mouse strains Lep ob /Lep ob and Lepr db /Lepr db , which lack leptin or its receptor, respectively. Adipose tissue from normal mice on a standard diet did not express the gene. The data indicated a role for HMGI-C in obesity. This was further elaborated by feeding a strain of pygmy mouse carrying two non-functional HMGI-C alleles (Hmgic À/À ), heterozygotes (Hmgic +/À ), and wild-type mice with standard or high-fat diets. Interestingly, both the Hmgic À/À and the Hmgic +/À mice did not increase in weight on a high-fat diet compared with the controls on a standard diet, whereas the wild-type mice increased in weight compared with their controls as expected. On a standard diet, the weight of the heterozygotes was not signi®cantly different from the wild-type mice. There were no differences in food intake. The observations indicated that lack of one or both of the HMGI-C alleles may protect against obesity induced by a high-fat diet and there seemed to be a haploinsuf®ciency effect of HMGI-C.
Anand & Chada (8) also studied effects of HMGI-C in the genetically obese Lep ob /Lep ob mice, which lack a functional leptin gene, by knocking out their HMGI-C gene also. Lack of HMGI-C resulted in a remarkable resistance against obesity, and the weights of the mice were only 27% of those of the leptin-de®cient controls by 30 weeks of age. In comparison, the weights of the Hmgic À/À mice with a normal leptin gene were 47% of those of the wild-type controls. Leptin-de®cient mice, which were heterozygous for the HMGI-C null mutation, had reduced expression of HMGI-C and their weights were 72% of those of the HMGI-C heterozygotes with a normal leptin gene. Greatest weight reduction was observed in the mesenteric fat pads. Both the appearance of the adipocytes and the expression of genes involved in adipogenesis were similar in leptinde®cient mice with or without functional HMGI-C. The decrease in fat-pad weight was therefore most likely to have been caused by a reduction in cell number. Although the absence of functional HMGI-C attenuated the weight increase in leptin-de®cient mice, they were still heavier than wild-type mice, indicating that there are pathways for adipocyte proliferation independent of HMGI-C.
Absence of HMGI-C reduced the accumulation of fat normally observed in the leptin-de®cient mice, but other phenotypic characteristics of leptin de®ciency were still present. As evaluated by the concentrations of plasma insulin and glucose, and glucosuria, the relatively lean double-homozygous HMGI-C and leptin-de®cient mice were as insulin resistant as their obese leptin-de®cient relatives with a normal HMGI-C gene. The study by Anand & Chada (8) indicates that insulin resistance in the Lep ob /Lep ob mouse is primarily caused by leptin de®ciency and not by obesity, and indirectly supports the ®ndings of previous studies in which anti-diabetic effects of leptin have been demonstrated ((9); reviewed in (10)).
HMGI-C facilitates the interaction between transcription factors and DNA, and seems to determine the growth potential of pre-adipocytes. The absence of HMGI-C expression in normal adult tissues, the appearance of HMGI-C in adipose tissue in obesity, and the gene-dosage effect observed in the studies of Anand & Chada (8) makes HMGI-C an ideal peripheral target for the treatment of obesity and a complement to interventions aimed at appetite suppression.
